You are here: Industry Insights > mRNA

News List

I-Mab Expands Next-Gen Novel Oncology Portfolio contractpharma
July 12, 2021
I-Mab, a clinical stage biopharmaceutical company developing novel biologics, signed two new collaborations with Immorna, an mRNA biotech company, and neoX Biotech, an AI-enabled R&D biotech company.
mRNA vaccines slash risk of COVID-19 infection by 91% in fully vaccinated people worldpharmanews
July 07, 2021
People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City.
Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology prnasia
July 02, 2021
Korea National Institute of Health (KNIH), Korea's top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.
Sanofi Launches Dedicated mRNA Vaccines CoE contractpharma
July 01, 2021
Approximately €400million investment annually aims to accelerate end-to-end R&D of next-generation vaccines.
Sanofi plans €400m investment in mRNA vaccines ‘centre of excellence’ pharmatimes
June 30, 2021
French pharma company Sanofi has announced that it will invest €400m into a new facility focused on solely on the development and delivery of next-generation mRNA-based vaccines.
Phase I trial of mRNA-based influenza vaccine begins europeanpharmaceuticalreview
June 24, 2021
The trial will assess a monovalent mRNA-based vaccine candidate against seasonal influenza caused by the A/H3N2 strain.
mRNA-based therapeutic cancer vaccine enters Phase II trial europeanpharmaceuticalreview
June 24, 2021
BioNTech is evaluating its investigational therapeutic mRNA-based cancer vaccine, BNT111, in combination with Libtayo® (cemiplimab) for the treatment of melanoma.
Study Suggests COVID Vaccine Booster Shots Will Be Needed drugs
June 24, 2021
One dose of a two-dose mRNA COVID-19 vaccine is enough to protect previously infected people, but it's likely they and everyone with two doses will still require booster shots at a later date, a new study suggests.
Sanofi and Translate Bio start clinical trial for mRNA flu vaccine expresspharma
June 23, 2021
The trial will evaluate the safety and immunogenicity of a monovalent flu vaccine candidate coding for the hemagglutinin protein of the A/H3N2 strain of the influenza virus.
Collaboration to develop novel polymer-based drug delivery system for mRNA europeanpharmaceuticalreview
June 22, 2021
Evonik and Stanford University will collaborate over three years to advance an innovative polymer-based drug delivery system that could further the use of mRNA therapeutics.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page